Medline Inc. (MDLN)

37.7 1.68 (4.68%)

As of 2026-05-19 14:59:58 EST

Medline Inc. is an American public healthcare company headquartered in Northfield, Illinois. In June 2021 it was acquired by a consortium of private equity firms Blackstone, Carlyle and Hellman & Friedman valuing the company at US$34 billion in one of the largest leveraged buyouts of all time. It was the nation's largest privately held manufacturer and distributor of medical supplies providing products, education, clinical programs and services across the continuum of care with operations in over 125 countries and territories.

Traded asNasdaq: MDLN
ISINUS58507V1070
CIK0002046386
LEI984500FAN6J1P8566D43
EIN331845288
SectorHealthcare
IndustrySurgical & Medical Instruments & Apparatus
CEOJim Boyle
Employees45,000
Fiscal Year End1231
Address3 LAKES DRIVE, NORTHFIELD, IL, 60093
Phone847-949-3000
Websitehttps://www.medline.com/
Stock Quotes
trading_symbolregistrant_nametimepricechangepercentage_change
MDLNMedline Inc.2026-05-19 14:59:5837.71.684.68
This is a preview of the latest data. Subscribe to access the full data.
Company Information
trading_symbolcentral_index_keyregistrant_nameisin_numberlei_numberein_numberexchangesic_codesic_descriptionfiscal_year_endstate_of_incorporationaddress_streetaddress_cityaddress_stateaddress_zip_codeaddress_countryaddress_country_codephone_numbermailing_addressbusiness_addressformer_nameindustryfounding_datechief_executive_officernumber_of_employeeswebsitemarket_capshares_issuedshares_outstandingdescriptionupdate_time
MDLN0002046386Medline Inc.US58507V1070984500FAN6J1P8566D43331845288Nasdaq3841Surgical & Medical Instruments & Apparatus1231DE3 LAKES DRIVENORTHFIELDIL60093UNITED STATESUS847-949-30003 LAKES DRIVE, NORTHFIELD, IL, 600933 LAKES DRIVE, NORTHFIELD, IL, 60093—Healthcare1966Jim Boyle45,000https://www.medline.com/13,000,000,000——Medline Inc. is an American public healthcare company headquartered in Northfield, Illinois. In June 2021 it was acquired by a consortium of private equity firms Blackstone, Carlyle and Hellman & Friedman valuing the company at US$34 billion in one of the largest leveraged buyouts of all time. It was the nation's largest privately held manufacturer and distributor of medical supplies providing products, education, clinical programs and services across the continuum of care with operations in over 125 countries and territories.2026-05-14 15:30:23
This is a preview of the latest data. Subscribe to access the full data.
MDLN Stock Price (End-of-Day)
This is a preview of the latest data. Subscribe to access the full data.
MDLN Stock Price (1-Minute)
This is a preview of the latest data. Subscribe to access the full data.
Market Cap
Fiscal YearMarket CapChange In Market CapPercentage Change In Market CapShares OutstandingChange In Shares OutstandingPercentage Change In Shares Outstanding
202513,000,000,00013,000,000,000100———
This is a preview of the latest data. Subscribe to access the full data.
Executive Compensation
Executive NameExecutive PositionFiscal YearSalaryBonusStock AwardsIncentive Plan CompensationOther CompensationTotal Compensation
Michael B. DrazinChief Financial Officer2025810,0000956,853763,11727,2892,557,259
Douglas P. GolwasChief Commercial Officer2025800,0000956,853772,41025,0302,554,293
James M. PigottPresident20251,100,00000930,5738,876,50410,907,077
Stephen L. MillerChief Operating Officer2025800,0000956,853676,7819,1402,442,774
James M. BoyleChief Executive Officer20251,250,00001,177,6651,409,96023,3473,860,972
This is a preview of the latest data. Subscribe to access the full data.
Employee Count
Fiscal YearEmployee Count
202545,000
This is a preview of the latest data. Subscribe to access the full data.
Income Statements
Fiscal Year2025
Revenue28,432,000,000
Cost Of Revenue20,914,000,000
Gross Profit7,518,000,000
Research And Development Expenses80,000,000
General And Administrative Expenses4,524,000,000
Operating Expenses5,306,000,000
Operating Income2,212,000,000
Net Income1,159,000,000
Earnings Per Share Basic-0.01
Earnings Per Share Diluted-0.01
Weighted Average Shares Outstanding Basic810,000,000
Weighted Average Shares Outstanding Diluted810,000,000
This is a preview of the latest data. Subscribe to access the full data.
Balance Sheet Statements
Fiscal Year2025
Cash And Cash Equivalents1,939,000,000
Marketable Securities Current—
Accounts Receivable3,533,000,000
Inventories4,769,000,000
Non Trade Receivables—
Other Assets Current438,000,000
Total Assets Current10,679,000,000
Marketable Securities Non Current—
Property Plant And Equipment4,778,000,000
Other Assets Non Current23,027,000,000
Total Assets Non Current5,210,000,000
Total Assets38,484,000,000
Accounts Payable961,000,000
Deferred Revenue—
Short Term Debt77,000,000
Other Liabilities Current1,452,000,000
Total Liabilities Current2,490,000,000
Long Term Debt12,484,000,000
Other Liabilities Non Current682,000,000
Total Liabilities Non Current16,708,000,000
Total Liabilities19,198,000,000
Common Stock0
Retained Earnings-7,000,000
Accumulated Other Comprehensive Income27,000,000
Total Shareholders Equity10,737,000,000
This is a preview of the latest data. Subscribe to access the full data.
Cash Flow Statements
Fiscal Year2025
Depreciation And Amortization1,011,000,000
Share Based Compensation Expense76,000,000
Other Non Cash Income Expense-13,000,000
Change In Accounts Receivable355,000,000
Change In Inventories264,000,000
Change In Non Trade Receivables—
Change In Other Assets126,000,000
Change In Accounts Payable73,000,000
Change In Other Liabilities-19,000,000
Cash From Operating Activities1,744,000,000
Purchases Of Marketable Securities—
Sales Of Marketable Securities—
Acquisition Of Property Plant And Equipment447,000,000
Acquisition Of Business-6,000,000
Other Investing Activities0
Cash From Investing Activities-474,000,000
Tax Withholding For Share Based Compensation—
Payments Of Dividends—
Issuance Of Common Stock7,008,000,000
Repurchase Of Common Stock33,000,000
Issuance Of Long Term Debt179,000,000
Repayment Of Long Term Debt—
Other Financing Activities—
Cash From Financing Activities399,000,000
Change In Cash1,692,000,000
Cash At End Of Period1,939,000,000
Income Taxes Paid62,000,000
Interest Paid944,000,000
This is a preview of the latest data. Subscribe to access the full data.
Insider Transactions
Insider NameRelationship To IssuerTransaction DateAmount Of SecuritiesAcquired Or DisposedSecurities Owned Following Transaction
BX Mozart ML-2 Holdco L.P.10% owner2026-03-1016,479,083D109,250,239
BX Mozart ML-2 Holdco L.P.10% owner2026-03-108,241,723D10,185
BX Mozart ML-2 Holdco L.P.10% owner2026-03-101,886,636D12,507,704
BX Mozart ML-2 Holdco L.P.10% owner2026-03-101,245,544D1,539
BX Mozart ML-2 Holdco L.P.10% owner2026-03-10366,337D2,428,681
This is a preview of the latest data. Subscribe to access the full data.
Institutional Holdings
Investor NamePeriod Of ReportMarket ValueAmount Of SecuritiesPrice Per Security
JANUS HENDERSON GROUP PLC2026-03-31506,545,57011,451,86144.2326
Arkadios Wealth Advisors2026-03-31530,26211,91644.5
Amundi2026-03-311,357,69730,51044.5001
EverSource Wealth Advisors, LLC2026-03-311,9594444.5227
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM2026-03-31790,72117,76944.5
This is a preview of the latest data. Subscribe to access the full data.
Mutual Fund Holdings
Registrant NamePeriod Of ReportFund NameFund SymbolAmount Of UnitsValue In UsdPercentage Value Compared To Assets
PARNASSUS FUNDS2026-03-31Institutional SharesPFPRX216,0009,612,0001.3199
PARNASSUS FUNDS2026-03-31Investor SharesPARNX216,0009,612,0001.3199
PARNASSUS FUNDS2026-03-31Institutional SharesPFPGX28,5361,269,8521.6122
PARNASSUS FUNDS2026-03-31Investor SharesPARMX351,13015,625,2850.6859
PARNASSUS FUNDS2026-03-31Investor SharesPFGEX28,5361,269,8521.6122
This is a preview of the latest data. Subscribe to access the full data.